Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Luminari

Showing results (91-100 of 210) with videos related to

Pageof 21
Sort By:
Oncology (Williston Park, N.Y.)|April 17, 2010
Reassessments of ESAs for cancer treatment in the US and EuropeCharles L Bennett, June M McKoy, Michael Henke, et al.
Hematological Oncology|July 27, 2007
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern ItalyStefano Luminari, Marina Cesaretti, Ivan Rashid, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
British Journal of Haematology|July 1, 2026
Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysisDaniele Caracciolo, Maria Rita Lombardo, Gianluca Reitano, et al.
RMD Open|August 28, 2023
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional studyGiulia Besutti, Chiara Marvisi, Pamela Mancuso, et al.
Revista Brasileira De Hematologia E Hemoterapia|August 14, 2016
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patientsMarcia Torresan Delamain, Maria Gomes da Silva, Eliana Cristina Martins Miranda, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
The Oncologist|July 27, 2019
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet NeedsMatthew J Matasar, Stefano Luminari, Paul M Barr, et al.
Haematologica|May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trialsPier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Leukemia & Lymphoma|September 16, 2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trialFortunato Morabito, Stefan Hohaus, Corrado Mammi, et al.
Pageof 21

Showing results (91-100 of 210) with videos related to

Sort By:
Pageof 21
Oncology (Williston Park, N.Y.)|April 17, 2010
Reassessments of ESAs for cancer treatment in the US and EuropeCharles L Bennett, June M McKoy, Michael Henke, et al.
Hematological Oncology|July 27, 2007
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern ItalyStefano Luminari, Marina Cesaretti, Ivan Rashid, et al.
Leukemia & Lymphoma|June 14, 2011
Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern ItalyStefano Luminari, Marina Cesaretti, Chiara Tomasello, et al.
British Journal of Haematology|July 1, 2026
Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysisDaniele Caracciolo, Maria Rita Lombardo, Gianluca Reitano, et al.
RMD Open|August 28, 2023
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional studyGiulia Besutti, Chiara Marvisi, Pamela Mancuso, et al.
Revista Brasileira De Hematologia E Hemoterapia|August 14, 2016
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patientsMarcia Torresan Delamain, Maria Gomes da Silva, Eliana Cristina Martins Miranda, et al.
British Journal of Haematology|December 8, 2011
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio LinfomiFrancesco Merli, Stefano Luminari, Fiorella Ilariucci, et al.
The Oncologist|July 27, 2019
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet NeedsMatthew J Matasar, Stefano Luminari, Paul M Barr, et al.
Haematologica|May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trialsPier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Leukemia & Lymphoma|September 16, 2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trialFortunato Morabito, Stefan Hohaus, Corrado Mammi, et al.
Pageof 21